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bilateral pressure hyperalgesia. LTT hypoesthesia was observed bilaterally for CRPS
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in the index arm relative to Arthritis patients. There were no differences between
Arthritis and Healthy participants for any QST outcome. In CRPS there were significant
correlations between LTT and pain outcomes bilaterally.
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ABSTRACT 
 
Objectives: This study aimed to identify relationships between sensory function and pain in 
common pain conditions (Arthritis, Complex Regional Pain Syndrome (CRPS) and 
Fibromyalgia Syndrome (FMS)) and healthy participants. Sensory abnormalities are known 
to be concomitant with some types of chronic pain but comparison across pain conditions 
using existing research is difficult due to methodological differences. Pragmatic Quantitative 
Sensory Testing (QST) methods were used. 
Methods: Hot and cold sensitivity, light touch threshold (LTT), two-point discrimination 
(TPD) and pressure pain threshold (PPT) were assessed in 143 participants (n=37 Healthy, 
n=34 Arthritis, n=36 CRPS, n=36 FMS). Outcomes were assessed in the index (‘affected’ or 
right) and contralateral arm. Participants also completed the Brief Pain Inventory and McGill 
Pain Questionnaire. 
Results: There were statistically significant differences between groups for all QST 
outcomes except TPD. Relative to healthy participants, FMS displayed heat and cold 
hyperesthesia in both arms and cold hyperesthesia in the contralateral arm. CRPS 
demonstrated no changes in thermal sensitivity demonstrated cold hyperesthesia only in the 
index arm, with no heat hyperesthesia. Both CRPS and FMS exhibited bilateral pressure 
hyperalgesia. LTT hypoesthesia was observed bilaterally for CRPS but only in the 
contralateral arm for FMS. CRPS and FMS had pressure hyperalgesia in the index arm 
relative to Arthritis patients. There were no differences between Arthritis and Healthy 
participants for any QST outcome. In CRPS there were significant correlations between LTT 
and pain outcomes bilaterally. 
Discussion: People with FMS and CRPS demonstrate extensive sensory dysfunction. 
Arthritis patients had sensory profiles closer to healthy participants. LTT may provide a 
clinically relevant and accessible assessment for CRPS. 
 
Key words: Arthritis, Complex Regional Pain Syndromes, Fibromyalgia, Pain Threshold, 
Sensation. 
 
MANUSCRIPT 
 
INTRODUCTION 
Sensory abnormalities have been identified in a range of chronic pain conditions and are 
related to pain experience. For example, increases over a three year period in mechanical 
hypoesthesia and hyperalgesia were associated with ongoing pain in Complex Regional 
Pain Syndrome (CRPS).1 In people with knee osteoarthritis (OA) undergoing joint 
replacement surgery, pre-operative heat hyperalgesia predicted post-operative analgesic 
consumption;2 and pre-operative pressure hyperalgesia at a distant point (the forearm) 
correlated with pain one year post-surgery.3 In Fibromyalgia Syndrome (FMS) hot and cold 
pain thresholds were associated with pain, fatigue, anxiety and depression;4 and with hand 
pain, sleep quality and number of tender points.5 Sensory assessment may therefore 
represent an important part of clinical examination. 
 
One of the difficulties in mapping sensory function across different pain conditions is the 
array of methodological approaches reported. The German Research Network on 
Neuropathic Pain (DFNS) produced a standardised QST protocol.6 However, it takes 
approximately 30 minutes for each body region and uses very specialist equipment. 
Additionally, most QST studies investigate specific patient groups in isolation, preventing 
comparisons between different conditions. Three exceptions7-9 all used the DFNS protocol. 
Maier et al.7 compared somatosensory function across different neuropathic pain conditions, 
demonstrating hyperalgesia to cold, heat, blunt pressure and pinprick; and dynamic 
mechanical hyperalgesia in CRPS. Blumenstiel et al.8 compared QST outcomes in the back 
and dorsum of the hand in chronic back pain, FMS and healthy controls. Back pain patients 
displayed pressure hyperalgesia and vibration hypoesthesia only in the back. Sensory 
changes were more pronounced in FMS. Tampin et al.9 compared cervical radiculopathy, 
FMS and healthy participants, finding similar patterns of thermal hyperesthesia and 
mechanical hypoesthesia/hyperalgesia between groups, although changes were more 
marked in FMS. One further study10 used alternative QST methods of pressure algometry 
and cuff algometry to compare different patient groups, finding that sensory function in 
recurrent low back pain (LBP) was comparable to healthy controls. There was a range of 
sensory changes in mild and severe LBP but these were more pronounced in FMS. 
 
The above studies demonstrate that using the same protocol facilitates comparison across 
clinical conditions. Sensory differences might be clinically important as they may indicate 
underlying pain mechanisms. Furthermore, exploring relationships between sensation and 
pain experience might highlight which abnormalities are most clinically relevant. However, 
there may be advantages in employing more pragmatic and relatively low cost assessments 
than the DFNS protocol. 
 
This study therefore aimed to use pragmatic QST methods (inexpensive modalities, 20 
minutes to assess multiple body regions) to assess sensory function in healthy volunteers 
and chronic pain patients (CRPS, FMS and Arthritis) and to explore the relationships with 
self-reported pain experience. It was hypothesised that the protocol would identify a) sensory 
abnormalities in chronic pain patients; b) greater sensory abnormalities in CRPS and FMS 
than Arthritis; and c) positive relationships between sensory abnormalities and two different 
measures of pain experience. 
 
 
MATERIALS & METHODS 
This was a multi-centre cross-sectional observational study conducted at the Royal National 
Hospital for Rheumatic Diseases, Bath, UK (RNHRD) and at Salford Hospital, Manchester, 
UK. The results reported here were part of a wider study investigating sensorimotor conflict 
and its relationship to behavioural and neurophysiological variables in these patient groups. 
For example, we have demonstrated that sensorimotor conflicts lead to greater self-reported 
sensory disturbances in CRPS and FMS than in Arthritis, and that such disturbances are 
related to pain intensity.11 The analysis of QST and pain measures is reported separately 
here to allow full consideration of the findings in relation to the relevant literature. Ethical 
approval was granted by the National Research Ethics Service Committee South West - 
Frenchay (11/SW/0246). 
 
Participants 
Participants were recruited from four distinct patient groups to reflect those reported in 
previous literature: Complex Regional Pain Syndrome Type 1 (CRPS), Fibromyalgia 
Syndrome (FMS), OsteoarthritisOA/Rheumatoid Arthritis (RA) (Arthritis), and healthy 
controls (Healthy) (Table 1). The decision to recruit a combined Arthritis group was based on 
the wish to have a comparator group that had predominantly joint-specific disease, 
regardless of the inflammatory component. The Healthy group was matched with the patient 
groups according to gender and age (within 10 year bands). Sample size calculations were 
based on Pressure Pain Threshold (PPT) data for the index finger reported by Fernández-
de-las-Peña et al.16 They found a mean PPT of 448.7kPa in healthy participants (n=20), with 
a standard deviation of 23.4kPa (calculated from the reported 95% confidence intervals as 
recommended by Higgins and Green17). In patients with carpal tunnel syndrome, they found 
a reduction in PPT of 167kPa compared to healthy participants. However, a much more 
conservative difference of just one standard deviation was used for the purposes of our 
sample size calculation. On the basis of multi-group comparisons, =0.05 and 90% power, a 
sample size of n=33 in each group was calculated. 
 
TABLE 1 HERE 
 
Patient identification: Potential participants were identified by the multidisciplinary teams 
from the outpatient departments and wards at the RNHRD, Bath and the musculoskeletal 
pain clinic at Salford Royal, Manchester. Patients were also recruited from a database of 
volunteers held by the North West England Primary Care Research Network (PCRN). 
Potential participants were given an invitation letter and an information sheet about the study 
by a member of the multidisciplinary team, or received this by mail in the case of PCRN 
volunteers.  
 
Healthy volunteer identification: Healthy volunteers were recruited from hospital staff, family 
members of patient participants and other professional contacts known to the researchers. 
They were given a letter of invitation and a participant information sheet.  
 
All potential participants were asked to contact the research team if they were interested in 
taking part. If they expressed an interest, the research associate employed on the project 
(JB) contacted them and arranged an appointment for assessment. Participants were given 
an opportunity to ask any questions about the study on the telephone and when attending 
for assessment, prior to providing written informed consent. Travel expenses were refunded 
and all participants were offered a £5 voucher for their time. 
 
Outcome measures 
The research associate conducted all assessments at both study sites. QST data were 
collected on both arms for all participants. The term ‘index arm’ has been used to identify the 
affected arm for those patients with unilateral arm pain. For all other participants (i.e. healthy 
volunteers and those with lower limb or multiple limb pain) the ‘index arm’ was randomly 
chosen to be the right arm (there were no statistically significant differences between left and 
right arms for any of the QST values in the healthy control group). The term ‘contralateral 
arm’ has been used to denote the unaffected limb in those with unilateral arm pain. For all 
other participants the ‘contralateral arm’ was the left arm. Due to variation in pathology 
between groups and variation in pain distribution within groups this classification was 
employed to facilitate comparison between groups on the effect of having pain in the limb 
being tested. Participants were positioned in upright sitting with the tested limb supported on 
a table placed to the side. Sensory assessment took approximately 20 minutes to complete 
using the following procedure. 
 
Hot and cold sensitivity: Hot and cold metal rollers (Therroll, Somedic Production AB, 
Sweden) were applied to both forearms. Where this was not possible with CRPS patients 
due to allodynia, they were tested on the area closest to the painful site that they could 
tolerate. The hot roller was set at 40oC and the cold roller at 25oC according to the 
manufacturer’s recommendations (equivalent to 7-8oC from normal skin temperature, 
normally within a non-painful range). Participants were asked to indicate if they could feel 
heat or cold and whether the stimulus was painful or not. This allowed an assessment of any 
paradoxical sensations such as cold stimuli being interpreted as heat.18 The intensity of 
thermal sensations and any associated pain was assessed using an 11 point numerical 
rating scale. One half of the scale related to the intensity of cold sensations and the other 
half related to heat sensation intensity as follows: 0=’Very painful’, 1=’Painful’, 2=’Faint pain’, 
3=’Cold’, 4=’Cool’, 5=’No thermal sensation’, 6=’Warm’, 7=’Hot’, 8=’Faint pain’, 9=’Painful’, 
10=’Very painful’. This was adapted slightly from the descriptors used by Berglund et al.18 
Both arms were tested three times, randomising the hot and cold rollers. The mean intensity 
ratings were used for analysis. 
 
Light Touch Threshold (LTT): LTT was assessed on both hands and at a distant site (the 
sternum). A series of Von Frey monofilaments of decreasing stiffness were firstly applied at 
right angles to the centre of the sternum and the participant was asked to indicate when the 
sensation of touch disappeared. The stiffness value of this monofilament was recorded (in 
grams, g). Monofilaments of increasing stiffness were then applied and participants were 
asked to indicate when the sensation of touch reappeared. This monofilament value was 
also recorded and the LTT was calculated as the mean of the disappearance and 
appearance thresholds. This process was repeated on the palmar surface of both index 
fingers. 
 
Pressure Pain Threshold (PPT): A digital algometer (Somedic Production AB, Sweden)19 
was used on the palmar aspect of the distal phalynx of the index finger of both hands. The 
device’s ‘pinch handle’ was used to squeeze the finger at a rate of 10kPa/s (using the 
device’s built-in slope indicator). A 1cm2 probe was used. Participants were asked to report 
when the sensation turned from one of pressure to one of pain, at which point the pressure 
was released and a reading was taken from the digital display (in kilopascals, kPa). Three 
measurements were taken from each hand and the mean used for analysis. 
 
Two Point Discrimination (TPD): TPD, the smallest distance between two points that 
participants could distinguish, was assessed using a caliper, moving from a larger to smaller 
distance between points. Assessment was conducted on the lateral aspect of the upper 
arms due to the glove-like distribution of pain and allodynia in many of the CRPS patients. 
This distance was recorded once for each arm (in mm). 
 
In addition to QST outcomes, patient-reported outcome measures related to pain were 
completed by all participants. These were the Brief Pain Inventory Short Form (BPI-SF)20 
and the Short Form McGill Pain Questionnaire Version 2 (SF-MPQ-2).21 The BPI-SF asks 
participants to rate on a scale of 0-10 their pain over the previous 24 hours and the extent to 
which pain has interfered with physical, social and psychological aspects of functioning. It 
generates two scales related to pain severity and pain interference (both with a maximum 
score of 10). Completion takes five minutes and it has been shown to be valid and reliable in 
a wide range of patients, including those with osteoarthritis.22 The SF-MPQ-2 also takes five 
minutes to complete and provides a comprehensive list of 22 pain descriptors rated on a 
scale of 0-10 that capture the quality of pain. The total score is derived as an average to 
generate a maximum score of 10. 
 
Data analysis 
Shapiro-Wilk tests were used to test the normality of data distributions. Non-parametric 
Kruskal-Wallis tests were used to compare QST values between groups (Bonferroni 
correction =0.051). Statistically significant findings were followed-up using post hoc Mann-
Whitney U tests to compare QST values between pairs of groups (Bonferroni correction 
=0.008). The relationships between QST variables and pain measures (BPI and SF-MPQ-
2) were tested using Spearman’s Rank Order correlation coefficients (=0.05). 
 
 
RESULTS 
A total of 143 participants took part in the research and the demographics and patient-
reported outcome measures for each of the groups are reported in Table 2. The Arthritis 
group (n=34) comprised 13 people with OA, 17 with RA and 4 with a dual diagnosis of OA 
and RA. The mean ± SD BPI intensity scores in each of these Arthritis subgroups were 2.87 
± 1.60, 2.68 ± 1.81 and 3.63 ± 2.26 respectively, suggesting that pain was largely 
comparable, except with a dual diagnosis. The groups were largely comparable on the basis 
of gender. However the Arthritis group was slightly older, had a longer disease duration, less 
severe pain and less pain interference than the other patient groups. The CRPS and FMS 
groups were similar on most variables, with the exception of pain distribution. 
 
TABLE 2 HERE 
 
Table 3 presents the data for the QST variables. Most QST data deviated from a normal 
distribution. Lg10 and Ln transformation failed to improve data distributions and therefore the 
median and interquartile values have been presented and . Iinferential analysis was 
conducted using non-parametric statistics throughout. 
 
TABLE 3 HERE 
 
CRPS and FMS patients were the only groups to display statistically significant sensory 
dysfunction relative to healthy participants. There were no significant differences in any QST 
measure between healthy participants and those with arthritis. There were also no significant 
differences in any QST measure between CRPS and FMS participants. 
 
Thermal stimuli: FMS patients displayed cold and heat hyperesthesia on both the index and 
contralateral arms but cold hyperaesthesia only on the contralateral arm. CRPS patients 
displayed cold hyperesthesia only on the index arm and failed to display changes in 
sensitivity to thermal stimuli heat hyperesthesia. The median intensity rating for cold stimuli 
were 3.00 (‘cold’) for all groups. For heat stimuli the median was 6.00 (‘warm’) for the 
Healthy, Arthritis and CRPS groups and slightly higher at 7.00 (‘hot’) for FMS. No 
participants in any group rated the cold stimulus as paradoxically hot (or vice versa). 
 
Light touch thresholds: LTT hypoesthesia was evident in both CRPS and FMS groups for the 
contralateral limb but only in CRPS patients for the index limb. There was a median increase 
in LTT in the index arm in the FMS group but this did not reach statistical significance. 
Although a No statistically significant difference in LTT (sternum) between groups was 
identified, there were no significant differences between individual pairs of groups once the 
Bonferroni correction for multiple testing was applied. There were non-significant median 
increases in LTT at the sternum in both CRPS and FMS and a median decrease in Arthritis 
relative to Healthy.  
 
Two point discrimination: There were no statistically significant differences in TPD between 
groups. There was a median increase in TPD in both the index and contralateral arm in FMS 
relative to Healthy participants but this was not statistically significant. 
 
Pressure pain thresholds: Both CRPS and FMS patients demonstrated pressure 
hyperalgesia in both limbs relative to Healthy participants.  
 
Relationship between QST outcomes and self-reported pain variables: QST outcomes were 
correlated against SF-MPQ-2, BPI Severity and BPI Interference data to investigate the 
relationships between QST and clinical pain variables. In the interests of brevity, only 
statistically significant QST variables are reported in Table 4 below.  
 
TABLE 4 HERE 
 
The results suggest that hypoesthesia to light touch is correlated with clinical pain outcomes 
in people with CRPS, on both the index and contralateral side. These correlations were 
stronger for the index arm (range r=0.51-0.70) than for the contralateral arm (range r=0.39-
0.57). A similar relationship was seen in FMS, but only with the MPQ and only for the index 
arm. There was a positive relationship between the intensity of heat sensation and the MPQ 
in those with Arthritis. No other QST modalities were correlated with any other clinical pain 
outcomes. 
 
 
DISCUSSION 
Overall the results suggested that sensory changes were more severe in CRPS and FMS. 
There was a general tendency towards cold and heat hyperesthesia, touch hypoesthesia 
and pressure hyperalgesia in both conditions. Differences were evident for both the index 
and contralateral arms, suggesting that sensory dysfunction might involve changes in central 
nervous system sensitivity; particularly given that the majority of participants in each group 
did not have arm pain as their primary complaint. There are more similarities between CRPS 
and FMS than the other groups, and people with Arthritis have sensory profiles that are 
largely similar to Healthy participants. LTT hypoesthesia seems to be closely correlated with 
patient-reported outcomes in CRPS.  Our pragmatic QST protocol demonstrated the ability 
to identify sensory abnormalities in chronic pain patients. 
 
The observed findings of heat and cold hyperesthesia in FMS reflect similar findings for 
warmth made by Kosek et al.23 and cold by Berglund et al.18 However Hurtig et al.5 and 
Desmeules et al.24 found no evidence of changes to thermal detection and da Silva et al.25 
found evidence of thermal hypoesthesia in FMS. In CRPS thermal hypoesthesia (as 
opposed to the cold hyperesthesia observed in the present investigation) has been more 
commonly observed.26-28 Wylde et al.29 previously found evidence of warm and cold 
hypoesthesia in patients with knee OA awaiting joint replacement surgery, whilst Kosek and 
Ordeberg19 found warm hyperesthesia but no changes to cold detection in hip OA patients 
awaiting hip replacement. The present study found no evidence of thermal 
hypo/hyperesthesia in Arthritis patients, although our participants are likely to have had less 
severe conditions than those included in those previous investigations. These differences in 
findings may also be a function of different methodological approaches. In particular, the 
current investigation rated the intensity of thermal sensations associated with two metal 
rollers at fixed temperatures (25oC and 40oC), as opposed to the more common method of 
determining detection thresholds using thermoelectric Peltier elements. Caution therefore 
needs to be taken with directly comparing findings. However, the present investigation was 
able to identify differences between groups using the Therroll method. Interestingly, there 
were no instances of paradoxical heat sensations with cold stimuli, contrary to previous 
evidence in FMS18 and acute CRPS26; although this was not found to be a major feature of 
chronic CRPS26 or in a later study by the same authors.27 
 
Light touch hypoesthesia has previously been observed in FMS,25 upper limb CRPS,27 knee 
OA29 and the feet of people with RA.30 Kosek et al.23 and Hurtig et al.5 found no changes in 
touch thresholds in FMS and Kosek and Ordeberg19 also found no differences in hip OA 
relative to a control group (although touch thresholds were found to improve following joint 
replacement surgery). Two-point discrimination was found to be increased in CRPS patients 
with dystonia28. The current findings are therefore largely in agreement with previous 
observations, although we did not see significant changes in LTT in Arthritis patients. 
Interestingly Reimer et al.1 found that there was a link between mechanical hypoesthesia 
and ongoing pain in CRPS over a 3 year period. The associations observed between LTT 
and patient-reported outcomes in the present investigation might provide further evidence of 
the potential importance of mechanical hypoesthesia in the generation and maintenance of 
pain and pain-related disability, particularly in CRPS. The correlation values for CRPS were 
slightly stronger for the index arm (r=0.51-0.70) when compared to the contralateral arm 
(r=0.39-0.57). 42% of the CRPS sample had arm symptoms as their primary complaint and 
this affected limb was tested as the ‘index’ limb in those cases. Greater mechanical 
hypoesthesia in the affected arm might therefore help to explain the slightly stronger 
relationships observed for the index arm. 
 
Pressure pain hyperalgesia is perhaps the most consistent finding in FMS,23,25,31 
CRPS,1,27,28,32 OA3,19,29 and RA.33 A systematic review and meta-analysis by Suokas et al.34 
supported evidence of pressure hyperalgesia in OA, at both the affected joint and at remote 
sites. However, evidence for pressure hyperalgesia in Arthritis was not found in the current 
study. Reimer et al.1 observed that increased sensitivity to mechanical pain was linked with 
ongoing pain in CRPS 3 years later. Giesecke et al.31 found that pressure hyperalgesia could 
be used in conjunction with psychological variables to identify subgroups of FMS patients. 
So, assessment of PPT might also prove to be an important clinical outcome. Indeed Wylde 
et al.35 found that PPT demonstrated the strongest test-retest reliability in people with knee 
OA shortlisted for joint replacement surgery when compared with LTT, thermal sensation 
thresholds and thermal pain thresholds. Furthermore, PPT was one of the most prevalent 
somatosensory abnormalities observed29 and correlated with post-operative pain.3  
 
It is important to acknowledge potential confounders such as inflammatory status, 
medication, generalised versus local pain, the presence or absence of upper limb pain and 
psychosocial factors. All these issues have the potential to complicate comparisons both 
within and between groups and to influence the inter-relationships between variables, for 
example the potential of analgesia to induce LTT hypoesthesia. Future research should 
more adequately account for some of these confounders, for example through investigation 
of the inter-relationships between factors in only one patient group, such as upper limb 
CRPS, like previous work in FMS.36 
 
Strengths and limitations 
A strength is that the same experimental protocol was applied to all patient groups, 
facilitating comparison. The protocol was designed to be pragmatic, taking approximately 20 
minutes to complete, and used relatively portable and inexpensive equipment. This is an 
important strength of the investigation because such methods might be more accessible to 
researchers and clinicians. As already discussed, however, this created difficulties in 
controlling potential confounding variables both within and between groups. 
 
Although the study recruited to the specified sample size, it is important to note that sample 
size calculations were based on PPT at the index finger.16 Therefore, the possibility of Type 
II errors cannot be discounted where trends towards group differences failed to reach 
statistical significance for some of the other outcome measures. However, the participant 
numbers in the present investigation (n=34-37) are relatively large when compared to other 
similar studies. For example, Blumenstiel et al.8 had groups sizes of n=20-23, Tampin et al.9 
n=22-31 per group Goubert et al.10 had group sizes of n=15-26. Only Maier et al.7 had a 
larger sample size, (n=51-403 per group). 
 
Pain severity, as measured by the BPI and MPQ, was much lower in the Arthritis group 
compared to FMS and CRPS and may partly explain why the sensory profile of this group 
did not differ from healthy participants. It should also be acknowledged that many 
participants did not have arm pain, complicating comparisons between pain conditions and 
between the ‘index’ and ‘contralateral’ arm. For example 21/36 people with CRPS (58%) had 
foot/leg pain as their primary complaint and therefore testing of the index arm is not a true 
reflection of the sensitivity of an affected limb in CRPS. There were trends towards hot and 
cold hyperaesthesia, touch hypoesthesia and pressure hyperalgesia in the index limb of 
those with CRPS affecting the upper limb, as compared to those with lower limb CRPS. 
However, those trends were not statistically significant. Nonetheless, the ability of the 
protocol to identify differences in sensory function between conditions despite such 
participant heterogeneity is very promising. Finally, it should also be acknowledged that the 
numerical rating scale used to rate the intensity of thermal sensation and pain has not 
previously been validated. 
 
Future research 
It would be interesting to determine the predictive validity of the sensory abnormalities 
identified in the present investigation, particularly LTT. Ideally future research should be 
performed on more homogenous patient populations, for example those with unilateral arm 
pain. That would better identify whether the protocol is able to identify differences between 
conditions and between affected and unaffected limbs. 
 
Conclusion 
This investigation demonstrated the ability of a pragmatic QST protocol to identify sensory 
abnormalities in chronic pain patients. As hypothesised, people with FMS and CRPS 
demonstrated extensive sensory dysfunction, whilst Arthritis patients had sensory profiles 
closer to healthy participants. LTT were found to correlate with patient-reported outcome 
measures in CRPS and may therefore provide a clinically relevant and accessible 
assessment for CRPS.  
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LEGENDS FOR TABLES 
 
 
Table 1. Inclusion and exclusion criteria. 
 
Table 2. Demographics and patient-reported outcome measures for each group. N/A = 
Not Applicable. *This figure includes those with unilateral arm pain plus those with multiple 
limb pain, all of whom had bilateral arm pain. 
 
Table 3. Median (Interquartile Range) values for each QST modality. Kruskal-Wallis 
tests were used to compare QST values between groups (* = statistically significant, 
Bonferroni correction [Symbol]=0.051). Post hoc Mann-Whitney U tests were used to 
compare QST values between pairs of groups († = statistically significant versus healthy, ‡ = 
statistically significant versus arthritis, both Bonferroni correction =0.008). [+] = increased 
sensitivity (hyperesthesia/hyperalgesia) versus healthy. [-] = decreased sensitivity 
(hypoesthesia/hypoalgesia) versus healthy. Where median values were identical, decisions 
on [+] and [-] were based on mean values. 
 
Table 4. Spearman’s Rank Order correlation coefficients exploring the relationship 
between QST variables and patient reported pain scores. * = statistically significant 
(=0.05) 
 
The reviewers’ comments are addressed in turn below. Associated changes are highlighted in red 
font within the revised manuscript.  
 
Reviewer Comments: 
Reviewer #1: This study investigates 3 different groups of chronic pain patients, CRPS, FM, arthritis 
(rheumatoid arthritis and osteoarthritis), and healthy controls using a QST protocol to test sensory 
dysfunction. The authors conclude that CRPS and FM patients display high sensory dysfunction in 
contrast to arthritis patients and healthy controls. Further, the authors surmise that light touch 
threshold (LTT) examination might provide a clinically relevant and accessible assessment for the 
CRPS and FM groups. The study is interesting however several issues should be resolved. 
RESPONSE: Thank you for these comments. We trust that we have addressed each of the issues 
raised below.  
 
Hypothesis 
The authors used the McGill Pain Questionnaire (MPQ) to measure pain quality as one measure.  
However no clear a priori hypothesis was reported in advance of the study.  
RESPONSE: Apologies if this was not clear but our final hypothesis at the end of the Introduction 
section (“c) positive relationships between sensory abnormalities and pain experience”) relates to 
both the MPQ and BPI. We have therefore clarified this issue by adding “…two different measures 
of…” to this sentence. We have also now clarified in the data analysis section that analysis of the 
relationships between QST measures and pain experience involved both the MPQ and BPI. We trust 
that this now clarifies the a priori hypothesis in relation to the MPQ.  
 
Method 
The arthritis group consists of both osteoarthritis and rheumatoid arthritis patients. The reviewer 
wonders why an inflammatory rheumatic and a non-inflammatory disease is put into a single 
group. What is the percentage of the RA patients? What is the DAS28 in RA and OA? Is this 
comparable? Is the pharmacological treatment (medication) in the RA patients comparable to the 
osteoarthritis patients? Inflammation is a potential confounder/covariate. 
RESPONSE: We agree that this is a little unorthodox and was a major point of discussion within the 
research team when designing the study. The overriding consideration and rationale for combining 
the conditions was to create a comparator group that had predominantly joint-specific disease, 
regardless of the inflammatory component. This was to provide contrast with the other clinical 
conditions, which were more likely to display symptoms associated with neurogenic pain and central 
sensitisation. This decision has now been justified under the ‘Participants’ section of the manuscript. 
Unfortunately we do not have DAS28 data but we have now conducted a descriptive analysis of BPI 
intensity between the Arthritis subgroups and have added details to the ‘Results’ section, as follows: 
“The Arthritis group (n=34) comprised 13 people with OA, 17 with RA and 4 with a dual diagnosis of 
OA and RA. The mean ± SD BPI intensity scores in each of these Arthritis subgroups were 2.87 ± 1.60, 
2.68 ± 1.81 and 3.63 ± 2.26 respectively, suggesting that pain was largely comparable, except with a 
dual diagnosis.” This would suggest, therefore that inflammatory/non-inflammatory status is 
unlikely to have been a major factor in this study. We have also now added further discussion 
related to potential confounders in the ‘Discussion’ section, as follows: “It is important to 
acknowledge potential confounders such as inflammatory status, medication, generalised versus 
local pain, the presence or absence of upper limb pain and psychosocial factors. All these issues have 
the potential to complicate comparisons both within and between groups and to influence the inter-
relationships between variables, for example the potential of analgesia to induce LTT hypoesthesia. 
Future research should more adequately account for some of these confounders, for example 
through investigation of the inter-relationships between factors in only one patient group, such as 
upper limb CRPS, like previous work in FMS.36” 
 
Response to Reviewers
The authors differed between the "index" (painful) and the contralateral arm. The right arm was 
used with healthy controls and bilateral pain patients. What is the reason for not applying a 
counterbalanced random procedure? 
RESPONSE: The research team discussed a range of different options for data analysis to provide a 
valid comparison with the index arm. The right arm was chosen at random after identifying that 
there were no statistically significant differences between left and right arms for any of the QST 
values in the healthy control group. The proportion of left arms identified as the index arm in the 
patient groups was very small (only 8 out of the 106 patients) and therefore counterbalancing would 
equate to only 2 or 3 of the 37 healthy participants being chosen at random to present data for the 
their left arm as the index limb. Given the lack of difference between left and right limbs this was 
considered unnecessary. This rationale has now been clarified in the ‘Outcome measures’ section of 
the ‘Material & Methods’.  
 
Statistics 
The authors reported that they used the Kruskal-Wallis Test instead of the ANOVA, because their 
data was not normally distributed. Due the significant range in pain intensity (BPI) and the wide 
standard deviations, the reviewer suggests looking at the lg10 transformation for normalization of 
the data and then to use the ANOVA with pain severity (BPI) as covariate. The influence of pain on 
sensory functions can also be examined in groups. 
RESPONSE: Thank you so much for this suggestion. Following your advice, we have performed Lg10 
transformation on the QST, unfortunately with no improvement in the normality of data 
distributions. We have also performed Ln transformation of the data, which similarly failed to 
improve the normality of distribution. We have therefore decided to maintain non-parametric 
analysis throughout but have now clearly reported in the ‘Results’ section attempts to transform the 
data to conduct parametric analysis. We trust that this is acceptable.  
 
The authors used an alpha of p<0.05. With multi variable comparisons, a conventional alpha is 
suggested. A p<0.006 in case of 8 tested variables is appropriate.  
RESPONSE: Bonferroni correction has already been applied to the alpha level for post-hoc pairwise 
comparisons between groups (6 pairwise comparisons = alpha 0.008). Given your suggestion, we are 
also happy to apply a Bonferroni correction to the results of the Friedman test to account for the 
multiple variables investigated. Five variables were tested (cold, heat, LTT, TPD and PPT) and 
therefore we have adjusted the alpha level to 0.01 for these analyses. We trust that this is 
acceptable. This now means that cold (index arm) and LTT (sternum) are no longer statistically 
significant and we have removed reference to post-hoc testing for these variables in Table 3 and 
adjusted the accompanying text accordingly. Please note that adjusting alpha on the basis of 8 
variables, as you originally suggested, or 11 variables (to account for testing of five variables on both 
the index and collateral arms and LTT on the sternum) makes no difference to the statistical 
significance of the other variables. We therefore trust that our decision to adjust on the basis of the 
5 variables is acceptable. 
 
Results 
The CRPS group included patients with arm and leg/feed pain. Are there fundamental sensory 
differences in CRPS patients with and without arm pain? 
RESPONSE: We have now looked very closely at the differences in sensory profile between those 
with and without arm pain in the CRPS group, as suggested. There were 15 CRPS patients with an 
affected upper limb (this was therefore also their ‘index’ limb) and 21 with an affected lower limb. 
As might be expected, there were trends towards hot and cold hyperaesthesia, touch hypoesthesia 
and pressure hyperalgesia in the index limb of those with CRPS affecting the upper limb. Only cold 
hyperaesthesia (p=0.033) and pressure hyperalgesia (p=0.016) were statistically significant at a level 
of 0.05 but this was not the case following Bonferroni correction. We have now commented on 
these observations in the ‘Discussion’ section. 
 
The reviewer recommends a redraft taking the above into consideration and will be happy to 
rereview the manuscript afterwards. 
RESPONSE: Thank you for your helpful comments. We hope that we have addressed these 
satisfactorily. 
 
Discussion. 
Since medication, inflammation, LTT and SF-MPQ 2 might correlated but vary within the groups, 
the reviewer recommends to discuss the influence of the confounder variables? 
RESPONSE: Thank you for this point. As outlined in relation to an earlier comment, additional 
discussion has now been added to the ‘Discussion’ section to address this. We trust that this is 
satisfactory. 
 
Limitations. 
The limitations should mention the heterogeneity (mechanical vs. inflammatory caused pain, 
heterogeneous influences of medication on sensory functions, arm vs. leg/feed pain, generalized 
vs. localized pain) within each group that makes a reliable analysis among groups difficult. The 
reviewer recommends a repetition of that study, using only the CRPS and comparing psychosocial 
subgroups (MPI, Turk et al, 1996) with respect to differences in sensory functions as measured by 
QST. 
RESPONSE: As already detailed, acknowledgement of the potential confounders has been added to 
the ‘Discussion’ section. This addition explicitly refers to the Turk et al 1996 paper as a potential 
model for exploring upper limb CRPS. This additional discussion has now been explicitly referred to 
in the ‘Strength and limitations’ section, as follows: “As already discussed, however, this created 
difficulties in controlling potential confounding variables both within and between groups.” 
 
Reviewer #2: Nice study of sensory testing in different groups. The sample size is good and the 
writing is clear. A few substantial suggestions: 
RESPONSE: Thank you for these positive comments. We have addressed each of your suggestions 
below. 
 
1) In general, it's pretty unusual to combine OA and RA. I'd strongly consider not doing that. At the 
very least, test for differences. 
RESPONSE: We trust that our explanation in response to a similar comment from Reviewer 1 
explains the rationale for doing this. This decision has now been justified under the ‘Participants’ 
section of the manuscript. 
 
2) The testing location on the arm is interesting. I like the standard approach, but some patients 
will have pain there, some not. Please report the % of patients in each group (presumably 0 in the 
controls) who had pain in the area of the arm being tested. 
RESPONSE: Unfortunately a range of slightly different test sites were used for each QST parameter 
(volar aspect of the forearm for hot and cold; palmar aspect of the index fingers and the sternum for 
LTT; palmar aspect of the index finger for PPT; and lateral aspect of the upper arm for TPD). We 
therefore did not specifically record the presence or absence of pain under each test site. However, 
we can confirm that all participants reporting ‘multiple’ limb pain had bilateral upper limb pain 
which means that the ‘index’ arm was painful in all of these cases. To make this clearer, we have 
now substituted the previous “Proportion of participants that included tests on an ‘affected’ arm, n 
(%)” data in Table 2 with “Proportion of participants that had pain in the index arm, n (%)*”. We 
have added a footnote to the table to clarify this, as follows: “*This figure includes those with 
unilateral arm pain plus those with multiple limb pain, all of whom had bilateral arm pain.” We have 
also updated the section in the ‘Discussion’ where this issue was discussed, adding some specific 
information about the CRPS group (see previous response to Reviewer 1 above). We hope that these 
changes are useful. 
 
3) Compare test results in patients with and without pain in the testing area. 
RESPONSE: As described in response to the previous point, and to the point made by Reviewer 1, we 
have presented some additional information in the ‘Discussion’ section specifically in relation to 
comparing the results of CRPS patients with and without arm pain. With respect, we do not feel that 
repeating such analysis for the other groups would add anything of note due to the lack of arm pain 
(n=0/37 (0%) in the Healthy group), the very small proportion with no arm pain (n=1/36 (3%) in the 
FMS group) and the observed lack of differences in QST measures (the Arthritis group). We hope 
that this is acceptable. 
 
4) It may be worth computing and analyzing difference scores (results at one arm minus results at 
the other) in several of the groups. 
RESPONSE: We have carefully considered this point and feel that it has been largely addressed in 
response to previous points concerning analysis of painful versus non-painful arms. We also feel that 
the existing text in the ‘Future research’ section addresses this issue, as follows: “Ideally future 
research should be performed on more homogenous patient populations, for example those with 
unilateral arm pain. That would better identify whether the protocol is able to identify differences 
between conditions and between affected and unaffected limbs.” We trust, therefore, that this issue 
has already been addressed. 
 
TABLES 
 
Table 1. Inclusion and exclusion criteria. 
Inclusion criteria Exclusion criteria 
All 
 ≥18 years old. 
 Men or women. 
 Able to cooperate. 
 Comorbidity affecting sensory 
processes. 
 Asymmetrical visible disfigurement 
of upper limbs (additional to that 
caused by chronic pain condition). 
Complex regional pain syndrome (CRPS) 
 Meet Budapest criteria for unilateral 
CRPS.12 
 Upper or lower limb affected. 
 Diagnosis of FMS or OA/RA. 
Fibromyalgia (FMS) 
 Meet American College of 
Rheumatology (ACR) criteria for 
FMS.13 
 Diagnosis of CRPS or OA/RA. 
 Osteoarthritis / Rheumatoid Arthritis (Arthritis) 
 Meet ACR clinical criteria for 
Rheumatoid Arthritis14 or National 
Institute for Health and Care 
Excellence clinical criteria for 
Osteoarthritis.15 
 Diagnosis of CRPS or FMS. 
Healthy volunteers (Healthy)  
 Matched for age (within 10 years) 
and gender with patient groups. 
 Formally diagnosed rheumatological 
disorders. 
Table
Table 2. Demographics and patient-reported outcome measures for each group. N/A = 
Not Applicable. *This figure includes those with unilateral arm pain plus those with multiple 
limb pain, all of whom had bilateral arm pain. 
Variable Healthy (n=37) Arthritis 
(n=34) 
CRPS (n=36) FMS (n=36) 
Age, years (mean ± 
SD) 
50.27 ± 15.28 58.35 ± 9.19 48.94 ± 13.70 51.03 ± 9.85 
Sex, Women : Men, n 29 : 8 30 : 4 29 : 7 28 : 8 
Duration of 
Condition, years 
(mean ± SD) 
N/A 13.69 ± 10.81 5.53 ± 3.55 6.06 ± 7.29 
Limb 
affected, 
n 
Right arm N/A 9 9 1 
Left arm N/A 2 6 0 
Right leg N/A 9 10 0 
Left leg N/A 3 11 1 
Multiple N/A 11 0 34 
Index arm tested, 
Left : Right, n 
0 : 37 2 : 32 6 : 30 0 : 36 
Proportion of 
participants that 
included tests on an 
‘affected’ arm, n (%) 
0/37 (0%) 11/34 (32%) 15/36 (42%) 1/36 (3%) 
Proportion of 
participants that had 
pain in the index arm, 
n (%)* 
0/37 (0%) 22/34 (65%) 15/36 (42%) 35/36 (97%) 
Brief Pain Inventory 
Severity, max 10 
(mean ± SD) 
0.50 ± 0.73 2.86 ± 1.75 5.35 ± 2.59 5.68 ± 1.33 
Brief Pain Inventory 
Interference, max 10 
(mean ± SD) 
0.05 ± 0.27 2.89 ± 2.14 6.03 ± 3.17 6.29 ± 2.10 
McGill Pain 
Questionnaire Total, 
max 10 (mean ± SD) 
0.00 ± 0.01 1.48 ± 1.07 4.51 ± 2.73 4.08 ± 1.51 
 
  
Table 3. Median (Interquartile Range) values for each QST modality. Kruskal-Wallis 
tests were used to compare QST values between groups (* = statistically significant, 
Bonferroni correction =0.051). Post hoc Mann-Whitney U tests were used to compare QST 
values between pairs of groups († = statistically significant versus healthy, ‡ = statistically 
significant versus arthritis, both Bonferroni correction =0.008). [+] = increased sensitivity 
(hyperesthesia/hyperalgesia) versus healthy. [-] = decreased sensitivity 
(hypoesthesia/hypoalgesia) versus healthy. Where median values were identical, decisions 
on [+] and [-] were based on mean values. 
QST Modality Healthy  
(n=37) 
Arthritis  
(n=34) 
CRPS  
(n=36) 
FMS  
(n=36) 
Between 
groups 
differences 
(Kruskal-
Wallis) 
Cold, 0-10 scale  
(Index Arm) 
3.00 (0.00) 3.00 (0.00) 3.00 (1.00)† 
[+] 
3.00 (1.00)† 
[+] 
p=0.048 
Cold, 0-10 scale  
(Contralateral 
Arm) 
3.00 (0.00) 3.00 (0.00) 3.00 (0.13) 3.00 (0.25)† 
[+] 
p=0.004* 
Heat, 0-10 scale  
(Index Arm) 
6.00 (0.00) 6.00 (1.00) 6.00 (1.00) 7.00 (1.00)† 
[+] 
p=0.001* 
Heat, 0-10 scale  
(Contralateral 
Arm) 
6.00 (0.00) 6.00 (1.00) 6.00 (1.00) 7.00 (1.00)† 
[+] 
p=0.005* 
LTT, g  
(Index Arm) 
0.06 (0.09) 0.06 (0.13) 0.14 (0.69)† 
[-] 
0.10 (0.21) p=0.002* 
LTT, g  0.06 (0.08) 0.10 (0.13) 0.12 (0.31)† 
[-] 
0.12 (0.23)† 
[-] 
p=0.004* 
(Contralateral 
Arm) 
LTT, g  
(Sternum) 
0.05 (0.11) 0.01 (0.11) 0.09 (0.70) 0.12 (0.49) p=0.018 
TPD, mm  
(Index Arm) 
4.00 (1.00) 4.00 (1.00) 4.00 (1.07) 4.50 (1.50) p=0.162 
TPD, mm  
(Contralateral 
Arm) 
4.00 (0.50) 4.00 (1.50) 4.00 (1.00) 4.50 (2.00) p=0.329 
PPT, kPa  
(Index Arm) 
280 (144) 301 (192) 182 (102)†‡ 
[+] 
196 (130)†‡ 
[+] 
p<0.001* 
PPT, kPa  
(Contralateral 
Arm) 
328 (151) 286 (198) 225 (169)† 
[+] 
221 (237)† 
[+] 
p<0.001* 
 
 
 
  
Table 4. Spearman’s Rank Order correlation coefficients exploring the relationship 
between QST variables and patient reported pain scores. * = statistically significant 
(p<0.05) 
Group SF-MPQ-2 BPI Severity BPI Interference 
Healthy Nil Nil Nil 
Arthritis Heat (Index Arm) 
r=0.37, p=0.033* 
Nil Nil 
CRPS LTT (Index Arm) 
r=0.69, p<0.001* 
LTT (Contralateral 
Arm) r=0.49, 
p=0.004* 
LTT (Index Arm) 
r=0.70, p<0.001* 
LTT (Contralateral 
Arm) r=0.57, 
p=0.001* 
LTT (Index Arm) 
r=0.51, p=0.003* 
LTT (Contralateral 
Arm) r=0.39, 
p=0.027* 
FMS LTT (Index Arm) 
r=0.47, p=0.006* 
Nil Nil 
 
 
 
 
